SCHEMBL22404434

SCHEMBL22404434

COC(=O)[C@H](C)C[C@H](C)NC(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ CA7 P43166 1/20 0.47
▸ CA12 O43570 1/20 0.44
▸ CA14 Q9ULX7 1/20 0.44
▸ CYP2D6 P10635 1/20 0.43
▸ CTSK P43235 8/20 0.42
▸ CTSS P25774 4/20 0.42
▸ CTSL P07711 2/20 0.42
▸ CTSB P07858 1/20 0.42
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ PSENEN Q9NZ42 1/20 0.38
▸ KLK5 Q9Y337 1/20 0.38
▸ CAPN1 P07384 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ NFKB2 Q00653 1/20 0.37
▸ RELA Q04206 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1912532 0.87 CYP1A2 (0.49) CA1CA2CA7CYP2D6CTSK
SCHEMBL13621256 0.85 CTSK (0.48) CA1CA2CA7CA12CA14
SCHEMBL19000135 0.85 CTSK (0.48) CA1CA2CA7CA12CA14
SCHEMBL6168773 0.85 CTSK (0.48) CA1CA2CA7CA12CA14
SCHEMBL6168769 0.85 CTSK (0.48) CA1CA2CA7CA12CA14
SCHEMBL1318454 0.85 CTSK (0.48) CA1CA2CA7CA12CA14
SCHEMBL15110725 0.84 CA1 (0.49) CA1CA2CA7CYP2D6CTSK
SCHEMBL31362899 0.83 CA1 (0.45) CA1CA2CA7CA12CA14
SCHEMBL4047833 0.83 CA1 (0.47) CA1CA2CA7CYP2D6CTSK
SCHEMBL21794738 0.83 CA2 (0.47) CA1CA2CA7CYP2D6CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11034671-B2 Apoptosis signal-regulating kinase inhibitors and uses thereof SICHUAN HAISCO PHARMACEUTICAL CO., LTD. (CN) 2021-06-15 — — US disclosed
US-20200283404-A1 APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS AND USES THEREOF SICHUAN HAISCO PHARMACEUTICAL CO., LTD. (CN) 2020-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200283404-A1 APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS AND USES THEREOF DAPK1, ATF1, BAD CA1 3934/4885CA2 3975/4885CA7 4690/4885
US-11034671-B2 Apoptosis signal-regulating kinase inhibitors and uses thereof DAPK1, ATF1, BAD CA1 3934/4885CA2 3975/4885CA7 4690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback